eXmoor pharma, and Virica Biotech Inc. (“Virica”), announced a new project funded in part through a joint Canada-UK government biomanufacturing collaboration.

Cellular Origins and Fresenius Kabi, an operating company of Fresenius, announces they have signed a development agreement that leverages each company’s expertise in cell and gene therapies (CGTs).

The American scientist Laura Seeholzer, Ph.D., Postdoctoral Fellow at the University of California, San Francisco, USA, has won the 2024 Eppendorf & Science Prize for Neurobiology.

Top line data show that the randomized Phase II study of TG4001 in combination with avelumab versus avelumab in patients with recurrent or metastatic HPV16-positive cervical and anogenital tumors did not meet the primary objective of improvement.

Vericheck ddPCR empty-full capsid kit combines measuring viral titer and capsid titer, providing a high-precision assessment for critical quality attributes of both protein and DNA in droplets.

Thermo Fisher Scientific Inc., will showcase its latest innovations enabling the molecule-to-medicine journey and host a series of sessions that feature industry developments during CPHI Milan 2024, Oct. 8-10, in Milan, Italy.

BD (Becton, Dickinson and Company) (NYSE: BDX), and ten23 health, announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

Owlstone Medical (“Owlstone”), announced it has entered into a Research Collaboration Agreement with the FDA’s Center for Devices and Radiological Health (“CDRH”) - Office of Science and Engineering Laboratories (OSEL).

INTEGRA Biosciences is pleased to announce the launch of the PIPETBOY GENIUS, the latest addition to its range of serological pipet controllers.

Lonza, announced it has completed its acquisition of the Genentech large-scale biologics manufacturing site in Vacaville, California (US) from Roche for USD 1.2 billion.